Net Cash Provided by (Used in) Operating Activities |
-20.4M |
USD |
+82.7% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
51.3M |
USD |
-70.3% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
150M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
89.3M |
shares |
+3.15% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
30.9M |
USD |
-43.7% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
87M |
USD |
+185% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
32.9M |
USD |
+84.6% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Gross |
26.5M |
USD |
-58.2% |
Q4 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
18.3M |
USD |
-0.6% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
6.34M |
USD |
-83.8% |
Q4 2024 |
FY 2024 |
Deferred Federal Income Tax Expense (Benefit) |
23.4M |
USD |
+45.8% |
Q1 2025 |
Q1 2025 |
Current Income Tax Expense (Benefit) |
8.74M |
USD |
+24.3% |
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
2.43B |
USD |
+3.93% |
Q2 2025 |
Q2 2025 |
Current State and Local Tax Expense (Benefit) |
1.77M |
USD |
-22% |
Q1 2025 |
Q1 2025 |
Current Federal Tax Expense (Benefit) |
696K |
USD |
-49.8% |
Q1 2025 |
Q1 2025 |
Share-based Payment Arrangement, Expense |
20.1M |
USD |
+15.9% |
Q2 2025 |
Q2 2025 |
Deferred State and Local Income Tax Expense (Benefit) |
-5.03M |
USD |
-308% |
Q1 2025 |
Q1 2025 |
Interest Expense |
104M |
USD |
+20.5% |
Q1 2024 |
Q1 2024 |